Low dose Amisulpride for very late onset schizophrenia-like psychosis: the ATLAS study

kiwihug-393309-unsplash

Elwira Lubos summarises the recent ATLAS RCT of antipsychotic treatment for very late-onset schizophrenia-like psychosis, which provides evidence for the effectiveness of a very low dose of Amisulpride (100 mg).

[read the full story...]

Poorer cardiovascular screening, diagnosis and management if you have a mental illness

nick-fewings-532590-unsplash

Joanne Wallace summarises a systematic review that highlights disparities in the management of cardiovascular risk factors in people with mental illness.

[read the full story...]

Sexual function matters to people living with serious mental illness

bryan-apen-567698-unsplash

Rudiger Pittrof and Elana Covshoff from SHRINE (Sexual and Reproductive Health Rights, Inclusion and Empowerment) explore a recent review, which looks at the impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.

[read the full story...]

How valid are hospital psychiatric diagnoses?

equalizer-2818803_1280

Vishal Bhavsar explores a recent study that uses data linkage to electronic patient records to assess the validity of selected mental health diagnoses in English Hospital Episode Statistics.

[read the full story...]

People with severe mental illness have more adverse outcomes from medical or surgical treatment

marcelo-leal-525139-unsplash

Laoise Renwick considers the findings of a recent systematic review on the safety of service users with severe mental illness receiving inpatient care on medical and surgical wards.

[read the full story...]

Understanding the genetics of antipsychotic treatment response

simone-van-der-koelen-611419-unsplash

Marcus Munafo looks at a Chinese genome-wide association study that claims to have identified some of the genes associated with response to antipsychotic treatment.

[read the full story...]

Improving outcomes for people with first episode psychosis

ryan-holloway-261284-unsplash

Elwira Lubos summarises a recent review of reviews looking at the evidence for improving outcomes in first-episode psychosis.

[read the full story...]

Antipsychotic effectiveness: the numbers don’t lie, check the scoreboard

Screen Shot 2018-03-12 at 15.16.57

Students and Teachers from the King’s College London PNoMH Distance Learning MSc summarise a major new meta-analysis that brings together the last 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia.

[read the full story...]

Risk factors and peripheral biomarkers for schizophrenia spectrum disorders

This 'umbrella review' aimed to systematically appraise the meta-analyses of observational studies on risk factors and peripheral biomarkers for schizophrenia spectrum disorders.

Marcus Munafo considers the findings of a systematic review of meta-analyses of observational studies, which looks at risk factors and peripheral biomarkers for psychotic disorders on the schizophrenia spectrum.

[read the full story...]

Antidepressants for depression in schizophrenia: when good-enough evidence is good enough

thought-catalog-505378

Carmine Pariante is positive about a recent systematic review and meta-analysis of antidepressants for the treatment of depression in schizophrenia.

[read the full story...]